
News|Articles|January 21, 2026
Investigation of Separation Conditions and Prep Purification of GLP-1 Receptor Agonist Semaglutide
Author(s)Shimadzu Corporation
The article describes a comprehensive automated prep purification workflow targeting semaglutide, a GLP-1 receptor agonist, using dedicated method development software to automatically optimize a gradient profile and search for conditions that meet the specified separation criteria. This was followed by scale-up to purification scale and streamlined confirmation of the purities of collected fractions using benchtop MALDI-TOF MS.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
A Question of Balance? Part III: Weighing Isn’t an Uncertain Process, Is It?
2
Best of the Week: The Industry–Academia Collaboration, Sample Injection Troubleshooting
3
The 2026 LCGC Lifetime Achievement and Emerging Leader in Chromatography Awards
4
Deep In The Heart of Texas: Pittcon 2026
5